发明名称 |
Modulation of pre-mRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease |
摘要 |
The present invention encompasses a class of compounds known as splice modulating oligonucleotides (SMOs) that modulate pre-mRNA splicing, thereby affecting expression and functionality of a specific protein in a cell. The present invention further provides compositions and methods for modulating pre-mRNA splicing using a SMO of the invention to abrogate disease-causing mutations in a protein. Accordingly, the present invention provides compositions and methods of treating a subject at risk of, susceptible to, or having a disease, disorder, or condition associated with aberrant or unwanted target pre-mRNA expression or activity. |
申请公布号 |
AU2010204639(B2) |
申请公布日期 |
2014.11.27 |
申请号 |
AU20100204639 |
申请日期 |
2010.01.14 |
申请人 |
PHILADELPHIA HEALTH AND EDUCATION CORPORATION |
发明人 |
LUTZ, GORDON J.;TALLENT, MELANIE K.;LYKENS, NICOLE MICHELE |
分类号 |
A61K48/00 |
主分类号 |
A61K48/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|